Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes mellitus with atherosclerotic cardiovascular diseaseca-mccqe1ca-rcpsc-im

A 62-year-old man with a 10-year history of type 2 diabetes and prior myocardial infarction takes metformin at maximal tolerated dose. His eGFR is 65 mL/min/1.73 m², HbA1c is 7.9%, and blood pressure and lipids are optimally controlled. According to Diabetes Canada, which additional agent is preferred to improve cardiovascular outcomes?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.